MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia R. Pyzer, David Avigan, Dina Stroopinsky et al.|Blood|2017Cited by 193
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host diseaseMyrna Nahas, Jacalyn Rosenblatt, Robert J. Soiffer et al.|Blood|2018Cited by 48
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”)Zeynep Belce Erton, Doruk Erkan, Alí Duarte‐García et al.|Lupus|2025Cited by 2
MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAsAthalia R. Pyzer, David Avigan, Dina Stroopinsky et al.|Blood|2016Cited by 2
Abstract 54: MUC1-C regulates PD-L1 expression in acute myeloid leukemia, via downregulation of miRNAsDina Stroopinsky, David Avigan, Athalia R. Pyzer et al.|Clinical Cancer Research|2017Cited by 2